Skin-mountable medical device
Abstract
The invention concerns a skin-mountable medical device (10) comprising a mounting plate (12) having a bottom side (26) attachable to the skin of a user, a medical module (14), in particular an analyte sensing device or a drug administration pump, and a snap connector (16) adapted to releasably attach the medical module (14) on the upper side (34) of the mounting plate (12), wherein the snap connector (16) has a release flap (16) that can be actuated by the user to detach the medical module (14), and the release flap (16) projects outwardly from the mounting plate (12) and at its bottom side (26) maintains a clearance (24) to avoid an interfering skin contact in use.

Term
12.2 yearsto projected expiry
Projected expiry 21 December 2038, counted from filing; an application has no term until it is granted.
- Priority and filed
- Published
- Today
- Projected expiry
13 claims: 8 independent, 5 dependent
- 1Skin-mountable medical device comprising:a mounting plate (12) having a bottom side (26) attachable to the skin of a user preferably via an adhesive pad (30), a medical module (14), in particular an analyte sensing device or a drug administration pump, a snap connector (16) adapted to releasably attach the medical module (14) on the upper side (34) of the mounting plate (12) opposite to the bottom side (26), wherein the snap connector (16) has a release flap (16) that can be actuated by the user to detach the medical module (14), and the release flap (16) projects outwardly from the mounting plate (12) and has an outer portion (44) which at its bottom side (26) maintains a clearance (24) to avoid an interfering contact in use.
- 8The medical device according to any of claims 1 to 7, wherein the snap connector (16) has a latch (18) that is connected to the mounting plate (12) and engages with the medical module (14) in a locking position, and wherein the latch (18) can be tilted outward by actuation of the release flap (16) so as to disengage from the medical module (14) in a release position.
- 9The medical device of claim 9, wherein the latch (18) has a hook portion (50) which is adapted to snap into a recess (20) of the medical module (14).
- 10The medical device according to any of claims 1 to 9, wherein the snap connector (16) has an inlet chamfer (52) which is construed to guide the medical module (14) into a locking position, wherein the inlet chamfer (52) is arranged at an acute angle with respect to the bottom side (26) of the mounting plate (12) .
Independent claims9
27 paragraphs, as filed
0001The invention relates to a skin-mountable medical device comprising a mounting plate having a bottom side attachable to the skin of a user preferably via an adhesive pad, a medical module, in particular an analyte sensing device or a drug administration pump, and a snap connector adapted to releasably attach the medical module on the upper side of the mounting plate opposite to the bottom side.
0002Such medical device is known from <patcit id="pcit0001" dnum="WO2009125398A2"><text>WO 2009/125398 A2</text></patcit>. There, the device comprises a skin-adherable cradle unit and a fluid dispensing unit, wherein the cradle unit has two latches and the dispensing unit is snap-fitted by operation of the latches 32, 34. For this purpose, the latches are configured as hook-like protrusions which are accommodated in complementary shaped grooves of the dispensing unit. However, <patcit id="pcit0002" dnum="WO2009125398A2"><text>WO 2009/125398 A2</text></patcit> fails to disclose details for user handling of the latches, and the latches appear susceptible to breakage upon insertion of the dispensing unit. Such breaking connections may lead to a loss of the medical device, which may even go unnoticed by the patient.
0003On this basis, the object of the invention is to further improve the known medical devices and to provide an easy-to-use design which simplifies user manipulation while avoiding assembly failures.
0004The combination of features stated in the independent claim is proposed to achieve this object. Advantageous embodiments and further developments of the invention are derived from the dependent claims.
0005The invention is based on the idea of improving user interaction by avoiding interfering contours or contact in the mechanical movement paths. Accordingly, it is proposed that wherein the snap connector has a release flap that can be actuated or pushed by the user to detach the medical module, wherein the release flap projects outwardly from the mounting plate and has an outer portion which at its bottom side maintains a clearance to avoid an interfering skin contact when used or pressed. In this way, the release flap is allowed to move prior to a skin contact, and the user is prevented from applying excessive forces against a skin abutment which may lead to material failure. Moreover, the effort and force for insertion of the medical module is reduced, as no movable part of the snap connector comes into skin contact, thus also avoiding a bending or deformation of the mounting plate. As a result, the user-device-interaction is improved, and the intended medical success is further supported.
0006Advantageously, where the bottom side of the mounting plate lies in a plane or is generally planar, the outer portion of the release flap should be arranged at a clearance distance of at least 2 mm, preferably at least 5 mm above this plane. In this way, there is provided sufficient tolerance for unimpeded movement of the flap.
0007In another advantageous configuration, where the release flap has an inner portion connected to the mounting plate, the distance of the inner portion to a plane which is defined by the bottom side of the mounting plate (or, in use, by the skin) should be smaller than the distance of the outer portion to said plane.
0008In this connection it is further advantageous when the bottom sides of the mounting plate and of the release flap each define a plane, and wherein said planes include an acute angle.
0009Preferably, said acute angle is at least 5°, preferably at least 10°.
0010In another advantageous embodiment, the bottom side of the release flap runs parallel to the bottom side of the mounting plate. In such a parallel configuration, the release flap may be directly attached to an upstanding part of a latch of the snap connector.
0011A particular advantageous embodiment further comprises that the release flap has an upstanding circumferential rim which in use faces away from the skin. Thereby, the user receives a haptic feedback when pressing his finger against the flap. Furthermore, the rim facing upwards avoids unintended slipping of the finger and thereby supports higher pressing forces.
0012In an advantageous embodiment, the snap connector has a latch that is connected to the mounting plate and engages with the medical module in a locking position, wherein the latch can be tilted outward by actuation of the release flap so as to disengage from the medical module in a release position.
0013For providing a mechanically secure connection, the latch has a hook portion which is adapted to snap into a recess of the medical module.
0014In order to support the application of the medical module onto the mounting plate, the snap connector has an inlet chamfer which is construed to guide the medical module into a locking position, wherein the inlet chamfer is arranged at an acute angle with respect to the bottom side of the mounting plate.
0015Another possibility for facilitating handling and improving joining provides that a securing bracket is provided for attaching the medical module, wherein the securing bracket and the snap connector are arranged at opposite ends of the mounting plate.
0016In still another advantageous configuration, the mounting plate and the release flap are formed as an integral, preferably injection-moulded plastic part.
0017The medical device according to any of claims 1 to 12, In an advantageous configuration for drug administration, a fitting can be arranged on the bottom plate to provide a skin access preferably for a cannula assembly of the medical module.
0018In the following, the invention is further elucidated on the basis of embodiment examples shown schematically in the drawings, where <dl id="dl0001"><dt>Fig. 1</dt><dd>is a perspective view of a body-wearable medical device including a mounting base with an improved release mechanism;</dd><dt>Fig. 2</dt><dd>is a perspective view of the medical device of <figref idref="f0001">fig. 1</figref>;</dd><dt>Fig. 3</dt><dd>is an enlarged view of the release mechanism of the medical device; and</dd><dt>Fig. 4</dt><dd>is a side view of the mounting base with a further embodiment of the release mechanism.</dd></dl>
0019Referring to <figref idref="f0001">fig. 1</figref>, a medical device 10 comprises a mounting base or plate 12, a medical module 14 in the form of a body-worn patch pump for administration of insulin and a release mechanism formed as a snap connector 16 which is adapted to releasably attach the medical module 14 on the mounting plate 12 e.g. for first time assembly or removal in case of temporarily non-use or replacement. For this purpose, the snap connector 16 comprises a latch 18 that engages with a recess or notch 20 in a sidewall of the medical module 14 and a release tap or flap 22 that can be pushed down by the user or patient into a bottom free space or clearance 24 such that the flap 22 is allowed to move prior to a skin contact.
0020The mounting plate 12 has a bottom side 26 which is attachable at an infusion site to the skin 28 of the user via a self-adhesive pad 30 which is protected on its adhesive side by a peel-off foil 32.
0021As can be seen best in <figref idref="f0001">fig. 2</figref>, the mounting plate 12 has a top or upper side 34 which in use faces away from the skin 28 and supports the medical module 14. The latch 18 and a securing hook or bracket 36 are provided at opposite ends of the oblong mounting plate 12 as upstanding elements on the upper side 34. An upstanding hollow fitting or socket 38 provides skin access for a cannula assembly (not shown).
0022At the joining area of the latch 18, the flap 22 is moulded onto the edge of the mounting plate 12, such that it projects outwardly and is tilted upwards away from the skin 28, as will be explained in more detail below. Advantageously, the flap 22 has a flat base portion 40 and an upstanding circumferential rim 42 on the free outer edge of the base portion facing away from the skin 28.
0023The mounting plate 12 including its attached elements, 18,22,36,38 may be formed as an integral one-piece plastic part, e.g. by injection-moulding.
0024As further illustrated in <figref idref="f0002">fig. 3</figref>, the outer portion 44 of the release flap 22 maintains at its bottom side clearance 24, such that the release flap 22 is allowed to move under a force implied by finger pressure without interference, thus avoiding contact to the skin 28 or the self-adhesive pad 30 arranged thereupon. Then, the outer clearance distance to a plane 46 defined by the skin 28 (or, coinciding therewith, defined by the flat bottom side 26 of the mounting plate 12) should be about 5 mm, when viewed in direction perpendicular to the plane 46.
0025<figref idref="f0002">Fig. 3</figref> further illustrates that the latch 18 has a hook portion 50 which is adapted to snap into the recess 20 of the medical module 14. The hook portion 50 is provided with an inlet chamfer 52 which guides the medical module 14 when introduced into the shown locking position. For this purpose, the inlet chamfer 52 is arranged at an acute angle with respect to the bottom side 26 of the mounting plate 12. For removal of the medical module 14, the latch 18 can be tilted outward (to the right in <figref idref="f0002">fig. 3</figref>) by actuation of the release flap 22 so as to disengage from the recess 20 in a release position.
0026In the embodiment of <figref idref="f0002">fig. 3</figref>, in order to allow a movement prior to an interfering skin contact, the distance of the connecting portion 48 of the flap 22 to the plane 46 should be smaller than the distance of the outer portion 44 to said plane 46. This can be realized arranging the flat bottom side 54 of the flap 22 under an acute angle α with respect to the skin 28 or plane 46. Preferably, said angle α is above 5°, e.g. around 10°.
0027In the embodiment of <figref idref="f0002">fig. 4</figref>, similar parts are indicated with similar reference signs as explained above. The main difference is in the arrangement of the release flap 22, which in this case on its bottom side runs at a distance parallel to the bottom side 26 of the mounting plate 12, thus maintain a free space with a constant clearance 24. In this configuration, the release flap 22 may be directly attached to the upstanding section of the latch 18.
3 sheets
Sheet 1 Sheet 2 Sheet 3
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| JP2022149020A | Cited by | Japan | Search report |
| WO2009125398A2 | Cites | World Intellectual Property Organization (WIPO) | Applicant |
| US2017224912A1 | Cites | United States of America | Search report |
| US6302866B1 | Cites | United States of America | Search report |
| US9248232B2 | Cites | United States of America | Search report |
22 members in 14 offices; this record represents the family
Members22
| Document | Office | Kind | |
|---|---|---|---|
| EP3669906A1This record | European Patent Office (EPO) | A1 | |
| CA3123330A1 | Canada | A1 | |
| WO2020127181A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2019409541A1 | Australia | A1 | |
| CN113164677A | China | A | |
| SG11202106667YA | Singapore | A | |
| MX2021007578A | Mexico | A | |
| BR112021011881A2 | Brazil | A2 | |
| IL284143A | Israel | A | |
| IL284143D0 | Israel | D0 | |
| US2021308370A1 | United States of America | A1 | |
| JP2022513522A | Japan | A | |
| KR20220118293A | Republic of Korea | A | |
| EP3669906B1 | European Patent Office (EPO) | B1 | |
| EP3669906C0 | European Patent Office (EPO) | C0 | |
| HUE063930T2 | Hungary | T2 | |
| ES2962854T3 | Spain | T3 | |
| JP7515482B2 | Japan | B2 | |
| IL284143B1 | Israel | B1 | |
| IL284143B2 | Israel | B2 | |
| KR102888540B1 | Republic of Korea | B1 | |
| US12544505B2 | United States of America | B2 |
56 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11 | U11 | CH | |
| Renewal fee for the european patent with unitary effect paidU20 | U20 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Renewal fee for the european patent with unitary effect paidU20 | U20 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Renewal fee for the european patent with unitary effect paidU20 | U20 | EP | |
| Request for unitary effect filedU01 | U01 | EP | |
| Unitary effect registeredU07 | U07 | EP | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Party data changed (applicant data changed or rights of an application transferred)RAP3 | RAP3 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP3 | RAP3 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting states (corrected)RBV | RBV | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: REQUEST FOR EXAMINATION WAS MADESTAA | STAA | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN PUBLISHEDSTAA | STAA | EP |
Numbers
- Publication
- 3669906
- Application
- 182151639
Titles3
- German
- AUF DER HAUT ANBRINGBARE MEDIZINISCHE VORRICHTUNG
- English
- SKIN-MOUNTABLE MEDICAL DEVICE
- French
- DISPOSITIF MÉDICAL POUVANT ÊTRE MONTÉ SUR LA PEAU
Classification
- CPC, 10
- A61M5/14244
- A61M5/14248
- A61M5/1413
- A61B5/6833
- A61M2209/088
- A61M2005/14264
- A61B5/145
- A61M2205/58
- A61M5/1723
- A61M2005/1726
- IPC, 2
- A61M5 142
- A61M5 14
Designated states44
- Contracting states, 38
- Albania
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
and 14 moreShow fewer
- Monaco
- North Macedonia
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Serbia
- Sweden
- Slovenia
- Slovakia
- San Marino
- Türkiye
- Extension states, 2
- Bosnia and Herzegovina
- Montenegro
- Validation states, 4
- Cambodia
- Morocco
- Republic of Moldova
- Tunisia